An Ultra-High Field Study of Cerebellar Pathology in Early Relapsing-Remitting Multiple Sclerosis Using MP2RAGE

Mário João Fartaria1, Kieran OʼBrien, Alexandra Şorega

  • 1From the *Advanced Clinical Imaging Technology, Siemens Healthcare AG; †Department of Radiology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland; ‡Centre for Advanced Imaging, University of Queensland; §Siemens Healthcare Pty Ltd, Brisbane, Queensland, Australia; ∥Department of Radiology, Valais Hospital, Sion, Switzerland; ¶Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA; #Signal Processing Laboratory, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; **Siemens Medical Solutions USA, Inc, Malvem, PA; ††Medical Image Analysis Laboratory, Centre d'Imagerie BioMédicale; and ‡‡Neuroimmunology Unit, Neurology, Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.

Investigative Radiology
|November 30, 2016
PubMed
Summary

Ultra-high-field 7T MP2RAGE MRI significantly improves detection of cerebellar lesions in early multiple sclerosis (MS) compared to 3T MRI. Higher resolution 7T imaging offers better anatomical detail of white and gray matter pathology in MS patients.

Related Concept Videos